How to Respond to FDA Form 483s and Warning Letters
July 10, 2017
Many medical device manufacturers receive FDA warning letters due to lack of preparation for the FDA inspection and/or an inadequate response to an FDA Form 483.
The manner in which manufacturers respond to the 483 is critical in mitigating potential compliance risks and preventing the issuance of a warning letter. This article by NSF’s Kristen Grumet, published in Medical Design and Outsourcing, explains six key steps manufacturers can take when issued the FDA Form 483.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Announces Participation in Sustainable Foods 2025, CNBC Docuseries
November 18, 2024In January 2025, Lisa Spicka de Bevacqua, NSF’s Director of Sustainability Consulting, will speak at the Sustainable Foods 2025 International Conference and Exhibition in London, UK.
Read the Story
NSF CEO Pedro Sancha Joins TIC Council's TIC Talks
November 7, 2024Pedro Sancha reflected on his career journey, leadership approach and insights into the future of public health and the TIC sector.
Read the Story
Look for the Butterfly and Celebrate Non-GMO Month this October
October 22, 2024NSF celebrates Non-GMO Month with Watkins and Mary's Whole Life, showcasing NSF certified products!
Read the Story
Pedro Sancha Joins TIC Council’s TIC Talks on November 4
October 17, 2024Register today to catch NSF CEO Pedro Sancha on the latest edition of the TIC Council’s TIC Talks.
Read the Story